Home / BDNEWS / bdnews24.com - Home / Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

April 05, 2021 BDNEWS, bdnews24.com - Home

India's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.

from bdnews24.com - Home https://ift.tt/31JIiXZ

No comments

Subscribe to: Post Comments ( Atom )